Fotona Nightlase therapy can be used on patients with snoring problems or for patients who suspect they have OSA. The Mallampati score is often used to predict whether a patient has OSA.
- Class I: Complete visualisation of the soft palate
- Class II: Complete visualisation of the uvula
- Class III: Visualisation of only the base of the uvula
- Class IV: Soft palate is not visible at all
If you have a Class I Mallampati airway score, it indicates a low potential for snoring, while a Class III or IV score means it is easier for your airway to be blocked by tissue and hence there is a higher risk of snoring. Essentially, the closer the soft palate is to the tongue, the smaller the airway and the greater the probability of snoring. The goal of Fotona Nightlase treatment is to improve patients’ airway size and bring them to as low a class as possible.
Fortunately, both snoring and Obstructive Sleep Apnea (OSA) can be treated with Fotona Nightlase therapy – a safe and non-invasive laser procedure that does the following:
- Stimulates collagen remodelling
- Rejuvenates and tightens the floppy oral mucosal tissues that lead to obstruction of airways
Fotona’s patented Er:YAG laser modality heats tissue at the back of the throat which contracts collagen and has a tightening effect on the oral mucosal tissue, expanding the airway and allowing air to flow more freely.
Unlike other non-surgical treatments for snoring and OSA such as oral appliances, NightLase therapy does not require any device to be worn during sleep.
Used by both doctors and dentists, Fotona Nightlase has been proven to have a high success rate in producing a positive change in sleep patterns. Multiple clinical studies show that up to 90% of patients reported significant improvement in their snoring and 80% reported much better breathing. Those with OSA also saw an 85% improvement after a course of three treatments.